Protective role of IL-33/ST2 axis in Con A-induced hepatitis

Vladislav Volarevic1, Marina Mitrovic, Marija Milovanovic

  • 1Department of Microbiology and Immunology, Centre for Molecular Medicine and Stem Cell Research, Faculty of Medicine, University of Kragujevac, Serbia.

Journal of Hepatology
|June 28, 2011
PubMed
Abstract

Insights

The Interleukin 33/ST2 pathway protects against Concanavalin A-induced liver injury by reducing inflammation and hepatocellular damage. This suggests the Interleukin 33/ST2 axis is a potential therapeutic target for fulminant hepatitis.

Area of Science:

  • Immunology
  • Hepatology
  • Inflammation research

Background:

  • Concanavalin A (ConA) induces liver injury, serving as a model for hepatitis.
  • Interleukin 33 (IL-33) and its receptor ST2 play roles in immune responses and inflammation.
  • The specific role of the IL-33/ST2 axis in ConA-induced liver injury requires further elucidation.

Purpose of the Study:

  • To investigate the function of the IL-33/ST2 axis in ConA-induced liver injury.
  • To determine the impact of IL-33/ST2 signaling on inflammatory pathology and hepatocellular damage.

Main Methods:

  • Comparison of ConA-induced hepatitis severity in ST2-deficient and wild-type mice.
  • Analysis of liver enzymes, histology, immune cell infiltration (including T cells, NK cells, and macrophages), cytokine production, and apoptosis markers.
  • Assessment of the effects of exogenous IL-33 administration in wild-type mice.

Main Results:

  • ST2-deficient mice exhibited exacerbated hepatitis with increased inflammatory cell infiltration and higher levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-17).
  • Wild-type mice showed higher numbers of regulatory T cells (CD4+Foxp3+).
  • IL-33 administration attenuated liver injury, reduced inflammation, promoted regulatory T cell expansion, and modulated apoptosis-related proteins (caspase 3, BAX, Bcl-2).

Conclusions:

  • The IL-33/ST2 axis plays a protective role by downregulating ConA-induced liver injury.
  • Targeting the IL-33/ST2 pathway may offer a therapeutic strategy for fulminant hepatitis.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...